Skip to main content

Table 2 Preoperative patient characteristics

From: Impact of patient-prosthesis mismatch on 30-day outcomes in young and middle-aged patients undergoing aortic valve replacement

 

Without PPM

With PPM

p

Age

61 (56–66)

64 (57–68)

0,046

Women

49 (35,5%)

18 (29,5%)

0,41

HT

77 (55,8%)

34 (55,7%)

0,99

DM

22 (15,9%)

15 (25%)

0,13

Hypercholesterolemia

70 (50,7%)

27 (44,3%)

0,4

BSA

1,82 ± 0,2

1,91 ± 0,16

0,002

BMI

28,84 ± 4,29

30,07 ± 4,27

0,086

Peripheral arterial disease

13 (9,4%)

11 (18%)

0,085

CPD

20 (14,5%)

11 (18%)

0,52

Previous stroke

4 (2,9%)

4 (6,6%)

0,22

Previous neurological dysfunction

4 (2,9%)

0 (0%)

0,18

Preoperative creatinine concentration

0,94 (0,8–1,09)

1 (0,86–1,17)

0,043

Previous AF

18 (13%)

7 (11,5%)

0,76

Previous AMI

1 (0,7%)

1 (1,6%)

0,55

LVD

16 (11,6%)

7 (11,5%)

0,98

SPHT

14 (10,1%)

9 (14,8%)

0,35

Peak transaortic pressure gradient

81 (70–91)

81 (71–93)

0,93

Associated aortic regurgitation

27 (19,6%)

16 (26,2%)

0,29

Emergency surgery

4 (2,9%)

1 (1,6%)

0,61

Logistic EuroSCORE

2,8 (2,1–4,6)

2,9 (2,1–5,1)

0,51

Previous pacemaker implantation

0 (0%)

2 (3,3%)

0,033

NYHA functional class III-IV

67 (48,6%)

30 (49,2%)

0,93

Etiology

   

Degenerative disease

90 (65,2%)

41 (67,2%)

0,78

Congenital disease

37 (26,8%)

13 (21,3%)

0,41

Rheumatic disease

11 (8%)

7 (11,5%)

0,43

  1. HT: HYPERTENSION; DM: DIABETES MELLITUS; BSA: BODY SURFACE AREA; BMI: BODY MASS INDEX; COPD: CHRONIC PULMONARY DISEASE; AF: ATRIAL FIBRILLATION; AMI; ACUTE MYOCARDIAL INFARCTATION; LVD: LEFT VENTRICULAR DYSFUNCTION; SPHT; SEVERE PULMONAR HYPERTENSION; NYHA: NEW YORK HEART ASSOCIATION.